人工智能对齐是你未来药物发现所需要的一切
1School of Informatics, Yunnan Normal University, Kunming, China.
Frontiers in artificial intelligence
|November 19, 2025
概括
人工智能 (AI) 与人类价值观的协调对于安全和有益的药物发现至关重要. 专注于以人为中心的AI确保了未来生物医学进步的强大和可解释的模型.
科学领域:
- 生物医学研究生物医学研究
- 人工智能的人工智能
- 药物发现 药物发现 药物发现
背景情况:
- 人工智能 (AI) 融入药物发现带来了重大机遇,但也带来了风险.
- 越来越复杂的AI需要与人类的价值观和目标保持一致,以确保安全和社会利益.
- 确保人工智能对齐对于降低风险和最大化人工智能在药物发现中的积极影响至关重要.
研究的目的:
- 在药物发现中探索人工智能对齐的概念和挑战.
- 强调以人为中心的AI开发和部署在这个领域的方法.
- 倡导人工智能对齐作为未来药物发现的基本原则.
主要方法:
- 研究以人为中心的人工智能对齐框架.
- 分析了将人类价值观整合到人工智能驱动的药物发现系统中的策略.
- 检查了提高人工智能模型稳定性和可解释性的方法.
主要成果:
- 确定了以人为中心的人工智能调整的流行的技术框架.
- 提供了对AI调整研究的挑战和进步的见解.
- 强调了人工智能模型在药物发现中的稳定性和可解释性的重要性.
结论:
- 以人为中心的人工智能对齐对于人工智能在药物发现中的负责任发展至关重要.
- 人类价值观的系统整合是开发可靠的人工智能系统的关键.
- 人工智能对齐被认为是未来人工智能驱动的药物发现的关键,也许是独一无二的要求.
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K


